Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pKM2L-phPOMC

Promoter Bank clone, Human pro-opiomelanocortin (POMC) promoter

Catalog number RDB05503
Resource name pKM2L-phPOMC
Alternative name p1914-3F
Clone info. PCR amplified human pro-opiomelanocortin (POMC) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 25169263 to 25168520(NC_000002.12); relatively -412 to +332, where +1 corresponds to 1 nt of NM_001035256.2.
Comment PCR cloning, forward primer, B6PB0042F: 5' ctgctcttcacagcatcaccctctc 3'; reverse primer, B6PB0042R: 5' gagggcggggacgctcggcggc 3'; Entire sequence of promoter region has not been confirmed. Promoter activity has not been analyzed.
Vector backbone pKM2L (RDB04026) (Plasmid)
Size of vector backbone 4.2 kb
Selectable markers Kan^r
Gene/insert name Human proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin) genomic DNA
Depositor|Developer DNA Bank, |
Other clones in our bank

External Database
Human proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin)

          Reference sequence
            J00290

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions set forth by the DEPOSITOR 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
          Additional terms and conditions for distribution The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。
          付加的提供条件 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB05503 pKM2L-phPOMC DNA solution

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          References and tips

          Electronic file

          Original reference

          Further references such as user reports and related articles (go to bottom)

          Featured content


          Sequence information

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB05503_A4Lm.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: M13_-40
          Sequence file: RDB05503_A4Lma.seq check
          >05503_05503_A4Lm_3_M13(-40)_C08_08.ab1
              1 CCAGCGGCTC AGCTTGCATG CCTGCAGGTC ATTTAAATAG GGATAACAGC GCGTAATGAT
             61 TAAGATCTCG AGCTCTAAGC TTCACATATG CATGCACTAG TGGCCTGCTC TTCACAGCAT
            121 CACCCTCTCC CCATTTAATG GTTTAGGTTA ACAGGACTTT TTCCTTGAGG CTTGGGACAC
            181 GGAAGGGAGC CTCCCCTAAA CCAGGCCCTT GGAGAGCAGG CCCCAGGGGA GCAGTGCAAC
            241 TCACCTTCAC ACCCACAAGA CGGCTCCTGA CTTCTGCTCC CTCCTCCCCT CCCCAAAGTG
            301 GAACAGAGAG AATATGATTC CCCACGACTT CCACATCACA GTTTCCAAAC AATGGGGAAA
            361 TCGGAGGCCT CCCCGTGTGC AGACGGTGAT ATTTACCGCC AAATGCGAAC CAGGCAGATG
            421 CCAGCCCCAG CACGCACGCA GGTAACTTCA CCCTCGCCTC AACGACCTCA GAGGCTGCCC
            481 GGCCTGCCCC ACACGGGGGT GCTAAGCCTC CCGCCCGTTC TAAGCGGAGA CCCAACGCCA
            541 TCCATAATTA AGTTCTTCCT GAGGGCGAGC GGCCAGGTGC GCCTTCGGCA GGACAGTGCT
            601 AATTCCAGCC CCTTTCCAGC GCGTCTCCCC GCGCTCGTCC CCCGTCTGGA AGCCCCCCTC
            661 CCACGCCCCG CGGCCCCCCT TCCCCTGGCC CGGGGAGCTG CTCCTTGTGC TGCCGGGAAG
            721 GTCAAAGTCC CGCGCCCACC AGGAGAGCTC GGCAAGTATA TAAGGACAGA GGAGCGCGGG
            781 ACCAAGCGGC GGCGAAGGAG GGGAAGAAGA GCCGCGACCG AGAGAGGCCG CCGAGCGTCC
            841 CCGCCCTCGC CTGTCGACGC GTAGAATTCA CCCGGGTACT GCAGAAGTTG GTCGTGAGGC
            901 ACTGGGCAGG TAAGTATCAA GGTTACAAGA CAGGTTTAAG GAGACCAATA GAAACTGGGC
            961 TTGTCGAGAC AGAGAAGACT CTTGCGTTTC TGATAGGCAC CTATTGGTCT TACTGACATC
           1021 CACTTTGCCT TTCTCTCCAC AGGTGTCCAC TCCCAGTTCA AATTACAGCT CTTTAAAGCT
           1081 AGAGTACTTT AATACGACTC ACTATAGGCT AGCCACCAAT GCCTCACGTG TACGACCCCG
          1141 AGCCAACGGC CAAAACGCCA ATTGATTCCA CCCTTTG
          //
          Primer: phRLR2
          Sequence file: RDB05503_A4Lmb.seq check
          >05503_05503_A4Lm_3_phRLR2_D08_11.ab1
              1 AACTCCTATT GCAGCCCAGT TTCTATTGGT CTCCTTAAAC CTGTCTTGTA ACCTTGATAC
             61 TTACCTGCCC AGTGCCTCAC GACCAACTTC TGCAGTACCC GGGTGAATTC TACGCGTCGA
            121 CAGGCGAGGG CGGGGACGCT CGGCGGCCTC TCTCGGTCGC GGCTCTTCTT CCCCTCCTTC
            181 GCCGCCGCTT GGTCCCGCGC TCCTCTGTCC TTATATACTT GCCGAGCTCT CCTGGTGGGC
            241 GCGGGACTTT GACCTTCCCG GCAGCACAAG GAGCAGCTCC CCGGGCCAGG GGAAGGGGGG
            301 CCGCGGGGCG TGGGAGGGGG GCTTCCAGAC GGGGGACGAG CGCGGGGAGA CGCGCTGGAA
            361 AGGGGCTGGA ATTAGCACTG TCCTGCCGAA GGCGCACCTG GCCGCTCGCC CTCAGGAAGA
            421 ACTTAATTAT GGATGGCGTT GGGTCTCCGC TTAGAACGGG CGGGAGGCTT AGCACCCCCG
            481 TGTGGGGCAG GCCGGGCAGC CTCTGAGGTC GTTGAGGCGA GGGTGAAGTT ACCTGCGTGC
            541 GTGCTGGGGC TGGCATCTGC CTGGTTCGCA TTTGGCGGTA AATATCACCG TCTGCACACG
            601 GGGAGGCCTC CGATTTCCCC ATTGTTTGGA AACTGTGATG TGGAAGTCGT GGGGAATCAT
            661 ATTCTCTCTG TTCCACTTTG GGGAGGGGAG GAGGGAGCAG AAGTCAGGAG CCGTCTTGTG
            721 GGTGTGAAGG TGAGTTGCAC TGCTCCCCTG GGGCCTGCTC TCCAAGGGCC TGGTTTAGGG
            781 GAGGCTCCCT TCCGTGTCCC AAGCCTCAAG GAAAAAGTCC TGTTAACCTA AACCATTAAA
            841 TGGGGAGAGG GTGATGCTGT GAAGAGCAGG CCACTAGTGC ATGCATATGT GAAGCTTAGA
            901 GCTCGAGATC TTAATCATTA CCCTGTTATC CCTATTTAAA TGACCTGCAG GCATGCAAGC
            961 TTGGCACTGG GCCGTCGTTT TACAACGTCG TGACTGGGAA AACCCTGGCG TTACCCAACT
           1021 TTAATCGCCT TGCAGCACAT CCCCCTTTCG CCAGCTGGCG TATAGCGAGA GGCCCCGCCA
           1081 CGATCGCCTT TCCCACAGTT GCGCAGCTGA TGGCCGATGC GATTTTATTC AACAAAGCCG
          1141 CCCGATTCCC CGTCCAAAGT CG
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles


          2022.05.18

          GNP_filter3_RDBDEP_html_220516.pl